News

Filter

Current filters:

None

55 to 64 of 96191 results

Dimension Therapeutics appoints Annalisa Jenkins as chief executive

Dimension Therapeutics appoints Annalisa Jenkins as chief executive

17-09-2014

Dimension Therapeutics, a US gene therapy company focused on rare diseases, has appointed Annalisa Jenkins…

BiotechnologyBoardroomDimension TheapeuticsDimension TherapeuticsUSA

Room for new products in metastatic prostate cancer treatment market, says GlobalData

Room for new products in metastatic prostate cancer treatment market, says GlobalData

17-09-2014

Although many new products have been launched since 2010 to treat metastatic castration-resistant prostate…

GlobalDataOncologyPharmaceuticalProductionResearchXtandiZytiga

Sanofi and MyoKardia ink deal for genetic heart disease research

Sanofi and MyoKardia ink deal for genetic heart disease research

17-09-2014

French pharma major Sanofi has signed a global collaboration with privately-held US firm MyoKardia to…

Cardio-vascularGlobalLicensingMyoKardiaPharmaceuticalResearchSanofi

Denovo Biopharma acquires Lilly’s enzastaurin for development as a personalized medicine

Denovo Biopharma acquires Lilly’s enzastaurin for development as a personalized medicine

17-09-2014

Privately-held San Diego, USA-based biotech firm Denovo Biopharma has acquired enzastaurin, a late-stage…

BiotechnologyDenovo BiopharmaEli LillyenzastaurinGlobalLicensingOncology

Political developments impacting medicines for Russia

Political developments impacting medicines for Russia

17-09-2014

Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides…

Markets & MarketingPharmaceuticalPoliticsRussia

First therapy under UK’s early access scheme to be Northwest Biotherapeutics’ DCVax-L

First therapy under UK’s early access scheme to be Northwest Biotherapeutics’ DCVax-L

17-09-2014

The UK’s Department of Health announced that DCVax-L, the dendritic cell-based vaccine from US company…

BiotechnologyDCVaxNorthwest BiotherapeuticsOncologyRegulationUK

FDA approves AstraZeneca’s Movantik for opioid-induced constipation

FDA approves AstraZeneca’s Movantik for opioid-induced constipation

17-09-2014

The US Food and Drug Administration yesterday approved Movantik (naloxegol), an oral treatment for opioid-induced…

AstraZenecaGastro-intestinalsMovantikNektar TherapeuticsPharmaceuticalRegulationUSA

55 to 64 of 96191 results

Back to top